HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Won-Jung Koh Selected Research

Rifabutin (Ansamycin)

1/2020Rifabutin Is Active against Mycobacterium abscessus in Mice.
12/2017Treatment outcomes of rifabutin-containing regimens for rifabutin-sensitive multidrug-resistant pulmonary tuberculosis.
9/2017Effect of a 150 mg dose of rifabutin on serum itraconazole levels in patients with coexisting chronic pulmonary aspergillosis and Mycobacterium avium complex lung disease.
1/2015Effect of rifampin and rifabutin on serum itraconazole levels in patients with chronic pulmonary aspergillosis and coexisting nontuberculous mycobacterial infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Won-Jung Koh Research Topics

Disease

62Lung Diseases (Lung Disease)
10/2021 - 07/2005
39Tuberculosis (Tuberculoses)
01/2020 - 04/2005
21Pulmonary Tuberculosis
01/2020 - 04/2004
21Infections
12/2019 - 04/2005
15Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
01/2019 - 09/2006
13Extensively Drug-Resistant Tuberculosis
01/2020 - 08/2008
7Pathologic Constriction (Stenosis)
08/2014 - 05/2009
5Neoplasms (Cancer)
01/2020 - 11/2009
5Bronchiectasis
09/2019 - 04/2005
5Latent Tuberculosis
11/2018 - 10/2007
5Pneumonia (Pneumonitis)
01/2014 - 01/2006
5Critical Illness (Critically Ill)
06/2013 - 05/2006
4Pulmonary Aspergillosis
10/2021 - 05/2014
4Bronchiolitis
09/2019 - 04/2005
4Chronic Obstructive Pulmonary Disease (COPD)
01/2017 - 12/2013
4Respiratory Insufficiency (Respiratory Failure)
01/2017 - 05/2007
4Lung Injury
12/2013 - 05/2005
4Septic Shock (Toxic Shock Syndrome)
10/2011 - 06/2007
3Disease Progression
01/2019 - 02/2016
3Inflammation (Inflammations)
01/2016 - 09/2010
3Hemoptysis
02/2015 - 06/2008
3Arthritis (Polyarthritis)
01/2015 - 10/2007
3Tracheal Stenosis
07/2013 - 05/2009
2Obstructive Lung Diseases (Obstructive Lung Disease)
04/2016 - 01/2016
2Peripheral Nervous System Diseases (PNS Diseases)
01/2016 - 08/2009
2Abdominal Obesity
11/2015 - 04/2015
2Metabolic Syndrome (Dysmetabolic Syndrome X)
04/2015 - 09/2010
2Pleural Effusion (Pleural Effusions)
04/2014 - 01/2006
2Necrosis
01/2013 - 05/2010
2Sepsis (Septicemia)
11/2012 - 05/2007
2Thrombocytopenia (Thrombopenia)
11/2012 - 11/2009
2Actinomycosis
04/2010 - 10/2005
2Acute Lung Injury
06/2007 - 12/2004

Drug/Important Bio-Agent (IBA)

39Anti-Bacterial Agents (Antibiotics)IBA
01/2021 - 10/2005
25Pharmaceutical PreparationsIBA
01/2020 - 09/2006
16MacrolidesIBA
09/2019 - 01/2008
12Rifampin (Rifampicin)FDA LinkGeneric
01/2019 - 04/2005
11Isoniazid (Ftivazide)FDA LinkGeneric
01/2019 - 04/2005
9Linezolid (Zyvox)FDA Link
01/2019 - 01/2009
9Interferon-gamma (Interferon, gamma)IBA
04/2015 - 04/2004
8FluoroquinolonesIBA
01/2019 - 10/2013
8GoldIBA
11/2018 - 01/2009
8SiliconesIBA
08/2014 - 05/2009
7AntigensIBA
11/2018 - 11/2012
7AcidsIBA
08/2016 - 04/2005
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2015 - 10/2007
6Ethambutol (Myambutol)FDA LinkGeneric
01/2019 - 04/2005
6Clarithromycin (Biaxin)FDA LinkGeneric
10/2016 - 02/2007
5PyrazinamideFDA LinkGeneric
01/2020 - 04/2005
5OPC-67683IBA
11/2019 - 06/2012
5Bronchodilator Agents (Bronchodilators)IBA
01/2017 - 12/2013
5CytokinesIBA
10/2016 - 12/2007
5InterferonsIBA
01/2015 - 12/2010
4Amikacin (A.M.K)FDA LinkGeneric
01/2021 - 11/2009
4Rifabutin (Ansamycin)FDA Link
01/2020 - 01/2015
4Levofloxacin (Levaquin)FDA Link
01/2019 - 10/2013
4Moxifloxacin (Avelox)FDA Link
01/2018 - 05/2013
4Adrenal Cortex Hormones (Corticosteroids)IBA
01/2016 - 09/2004
4Interferon gamma ReceptorIBA
11/2007 - 04/2005
3Clofazimine (Lamprene)FDA Link
10/2021 - 01/2017
3Biomarkers (Surrogate Marker)IBA
01/2020 - 01/2016
3Streptomycin (Streptomycin Sulfate)FDA Link
01/2018 - 07/2010
3C-Reactive ProteinIBA
01/2016 - 03/2012
3EnzymesIBA
08/2013 - 12/2007
2RifamycinsIBA
01/2020 - 09/2017
2SeleniumIBA
05/2019 - 07/2015
2Trace Elements (Biometals)IBA
05/2019 - 07/2015
2CopperIBA
05/2019 - 07/2015
2ZincIBA
05/2019 - 07/2015
2CobaltIBA
05/2019 - 07/2015
2VitaminsIBA
02/2019 - 01/2017
2Methylmalonic AcidIBA
02/2019 - 01/2017
2Peptides (Polypeptides)IBA
11/2018 - 01/2006
2Ofloxacin (Ofloxacine)FDA LinkGeneric
01/2018 - 07/2010
2Itraconazole (Sporanox)FDA LinkGeneric
09/2017 - 01/2015
2Immunoglobulin A (IgA)IBA
01/2017 - 08/2013
2Azithromycin (Zithromax)FDA LinkGeneric
10/2016 - 11/2014
2InterleukinsIBA
04/2015 - 07/2008
2DNA (Deoxyribonucleic Acid)IBA
08/2013 - 11/2010
2Codon (Codons)IBA
08/2013 - 07/2005
2ImmunosorbentsIBA
02/2013 - 12/2007
2trichostatin A (A 300)IBA
06/2012 - 08/2009
2Tumor Necrosis Factor InhibitorsIBA
12/2011 - 10/2007
2Hydrocortisone (Cortisol)FDA LinkGeneric
10/2011 - 06/2007
2Adrenocorticotropic Hormone (ACTH)FDA Link
10/2011 - 06/2007
2Toll-Like Receptor 2IBA
09/2008 - 07/2006
2LipopolysaccharidesIBA
12/2007 - 01/2006
116S Ribosomal RNAIBA
01/2021
1Prothionamide (Protionamide)IBA
01/2020

Therapy/Procedure

39Therapeutics
09/2019 - 04/2004
8Drug Therapy (Chemotherapy)
02/2015 - 05/2006
8Stents
10/2013 - 05/2009
5Artificial Respiration (Mechanical Ventilation)
06/2014 - 05/2005
4Duration of Therapy
10/2021 - 01/2008
4Aftercare (After-Treatment)
01/2017 - 12/2010
3Positive-Pressure Respiration (Positive End-Expiratory Pressure)
12/2013 - 05/2005
2Salvage Therapy
01/2018 - 01/2017
2Respiratory Therapy (Therapy, Respiratory)
01/2018 - 04/2004
2Pneumonectomy (Lung Volume Reduction)
04/2016 - 04/2007
2Mechanical Ventilators (Ventilator)
12/2013 - 06/2013